Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial - The Lancet
VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer | 2 Minute Medicine
Why I'm taking tamoxifen to avoid breast cancer | MD Anderson Cancer Center
Practical Steps to Prevent Breast Cancer: Day 9 - If High Risk: Consider Risk-Reducing Medications | Public Health Sciences Division | Washington University in St. Louis
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models | npj Breast Cancer
Tamoxifen Not Associated With Higher Risk for Cataracts in Women With DCIS - Oncology Nurse Advisor
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic | British Journal of Cancer
Medicina | Free Full-Text | Pharmacogenomics, CYP2D6, and Tamoxifen: A Survey of the Reasons Sustaining European Clinical Practice Paradigms
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial - The Lancet
Cognitive Bias: The Downside of Shared Decision Making | JCO Clinical Cancer Informatics
Making Choices
Tamoxifen and Breast Cancer (Yale Fastback Series): DeGregorio, Michael W., Wiebe, Valerie J.: 9780300079517: Amazon.com: Books
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial - The Lancet
Tamoxifen Accelerates Endothelial Healing by Targeting ERα in Smooth Muscle Cells | Circulation Research
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - The Lancet Oncology
Tamoxifen to prevent breast cancer? - Website for Liz O'Riordan
Why So Many of Us Quit Taking Tamoxifen | FORCE: Facing our Risk of Cancer Empowered Blog
Breast cancer treatment without tamoxifen drug - non prescription
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 | Nature Communications
.jpg "Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis")
Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis
Gels | Free Full-Text | Tamoxifen Citrate Containing Topical Nanoemulgel Prepared by Ultrasonication Technique: Formulation Design and In Vitro Evaluation
5 tips for scientific survival from the Father of Tamoxifen
CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation: Molecular Therapy - Oncolytics
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial - The Lancet
